138 related articles for article (PubMed ID: 29731893)
21. RELB: A novel prognostic marker for glioblastoma as identified by population-based analysis.
Zeng F; Wang K; Huang R; Liu Y; Zhang Y; Hu H
Oncol Lett; 2019 Jul; 18(1):386-394. PubMed ID: 31289510
[TBL] [Abstract][Full Text] [Related]
22. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
Front Oncol; 2020; 10():1119. PubMed ID: 32974125
[No Abstract] [Full Text] [Related]
23.
Huang SP; Chang YC; Low QH; Wu ATH; Chen CL; Lin YF; Hsiao M
Oncotarget; 2017 Dec; 8(69):113766-113791. PubMed ID: 29371945
[TBL] [Abstract][Full Text] [Related]
24. Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype.
Lv J; Yang H; Wang X; He R; Ding L; Sun X
Cancer Biomark; 2018; 22(2):311-316. PubMed ID: 29660900
[TBL] [Abstract][Full Text] [Related]
25. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
26. SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma.
Ye LJ; Xu KM; Bai G; Yuan J; Ran FM
Oncol Lett; 2023 Aug; 26(2):348. PubMed ID: 37427339
[TBL] [Abstract][Full Text] [Related]
27. IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
Zhu C; Chen X; Guan G; Zou C; Guo Q; Cheng P; Cheng W; Wu A
Onco Targets Ther; 2020; 13():1129-1143. PubMed ID: 32103982
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.
Sun LH; Yang FQ; Zhang CB; Wu YP; Liang JS; Jin S; Wang Z; Wang HJ; Bao ZS; Yang ZX; Jiang T
CNS Neurosci Ther; 2017 Jan; 23(1):69-75. PubMed ID: 27637748
[TBL] [Abstract][Full Text] [Related]
29. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of EP300-interacting inhibitor of differentiation 3 predicts poor prognosis in patients with glioblastoma multiforme.
Diao PY; Li SX; Peng J; Yang JH; Pan YC; Xu XP; Tang H; Hu JX; Zhao HF; Huang GD
Int J Clin Exp Pathol; 2020; 13(5):979-988. PubMed ID: 32509069
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.
Mao L; Whitehead CA; Paradiso L; Kaye AH; Morokoff AP; Luwor RB; Stylli SS
J Neurosurg; 2018 Sep; 129(3):598-610. PubMed ID: 29148898
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Ji X; Zhu H; Dai X; Xi Y; Sheng Y; Gao C; Liu H; Xue Y; Liu J; Shi J; Zhang Y; Chen Y; Dai X; Li M; Wang A; Dong J
Cancer Biomark; 2019; 25(3):275-290. PubMed ID: 29991124
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of
Jin FQ; Jin L; Wang YL
Open Life Sci; 2021; 16(1):1164-1174. PubMed ID: 34722888
[No Abstract] [Full Text] [Related]
34. Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.
Ye N; Jiang N; Feng C; Wang F; Zhang H; Bai HX; Yang L; Su Y; Huang C; Wanggou S; Li X
J Cancer; 2019; 10(22):5536-5548. PubMed ID: 31632497
[TBL] [Abstract][Full Text] [Related]
35. LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages.
Hu WM; Yang YZ; Zhang TZ; Qin CF; Li XN
Front Med (Lausanne); 2020; 7():182. PubMed ID: 32528967
[No Abstract] [Full Text] [Related]
36. Bromodomain-containing protein 4 activates cardiotrophin-like cytokine factor 1, an unfavorable prognostic biomarker, and promotes glioblastoma
Shen SH; Guo JF; Huang J; Zhang Q; Cui Y
Ann Transl Med; 2022 Apr; 10(8):475. PubMed ID: 35571403
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
[TBL] [Abstract][Full Text] [Related]
38. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D
Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971
[TBL] [Abstract][Full Text] [Related]
39. Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
Yang P; Zhang C; Cai J; You G; Wang Y; Qiu X; Li S; Wu C; Yao K; Li W; Peng X; Zhang W; Jiang T
Oncotarget; 2016 Nov; 7(48):80091-80100. PubMed ID: 27590514
[TBL] [Abstract][Full Text] [Related]
40. Identification of Prominent Genes between 3D Glioblastoma Models and Clinical Samples via GEO/TCGA/CGGA Data Analysis.
Phon BWS; Bhuvanendran S; Ayub Q; Radhakrishnan AK; Kamarudin MNA
Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
